Duration of clopidogrel-based dual antiplatelet therapy and clinical outcomes after endeavor sprint zotarolimus-eluting stent implantation in patients presenting with acute coronary syndrome
Pil Sang Song(Inje University Haeundae Paik Hospital), Hyeon‐Cheol Gwon(Samsung Medical Center), Hyo‐Soo Kim(Inje University Ilsan Paik Hospital), Young Bin Song(Samsung Medical Center), Dong Ryeol Ryu(Kangwon National University Hospital), Jin‐Ok Jeong(Chungnam National University Hospital), Jin‐Ho Choi(Soonchunhyang University), Joo‐Yong Hahn(Samsung Medical Center), Hun Sik Park(Kyungpook National University Hospital), Seung‐Hyuk Choi(Seoul National University of Science and Technology), Doo‐Il Kim(Inje University Haeundae Paik Hospital), Seung‐Ho Hur(Keimyung University Dongsan Medical Center)
Cited by 7
Related Papers
Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease
|New England Journal of Medicine|2011|683
Effect of Intravascular Ultrasound–Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation
|JAMA|2015|603
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
|New England Journal of Medicine|2010|510
Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease
|New England Journal of Medicine|2015|505
Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
|New England Journal of Medicine|2008|493